Clinical Report: AI in Retina: Accuracy First
Overview
A study by the Macular Society reveals that patients with macular disease prioritize accuracy and verification over the identity of the decision-maker (AI vs. human) in retreatment decisions. The findings suggest that enhancing patient trust in AI requires a focus on performance metrics rather than the technology itself.
Background
As artificial intelligence (AI) tools transition from research to clinical practice in ophthalmology, understanding patient comfort with AI's role in treatment decisions is crucial. This is particularly relevant in macular services, where treatment choices can significantly impact vision outcomes. The study highlights the importance of patient preferences in the integration of AI into clinical workflows.
Data Highlights
| Factor | Importance (%) |
|---|---|
| Error rate | 34.4 |
| Second reader/checker | 33.6 |
Key Findings
- Patients prioritize error rate and the presence of a second reader/checker in AI-led treatment decisions.
- 43% of participants had wet AMD, and 35% had dry AMD.
- Participants showed no significant preference for human versus AI as the first reader.
- Many patients suggested that a human making final decisions with AI support could be optimal.
- Trust in AI can be enhanced by focusing on accuracy, transparency, and speed.
Clinical Implications
Clinicians should prioritize the accuracy and reliability of AI systems in macular disease management to foster patient trust. Emphasizing the role of human oversight in AI-assisted decisions may also improve patient acceptance and satisfaction.
Conclusion
The study underscores the need for a patient-centered approach in the adoption of AI in ophthalmology, focusing on performance and verification rather than the technology itself.
References
- The acceptability to patients with macular disease to have retreatment decisions being made by artificial intelligence | Eye Open, 2025 -- Study
- Study: AI Delivers High Accuracy in IRD Diagnosis, Retinal Physician, 2025 -- Article
- AI Advances for Diabetic Retinopathy, Ophthalmology Management, 2023 -- Article
- Diabetic Retinopathy Preferred Practice Pattern® - PubMed, 2025 -- Article
- Retinal Physician — Study: AI Delivers High Accuracy in IRD Diagnosis
- Retinal Physician — Artificial Intelligence to Manage the AMD Burden
- Diabetic Retinopathy Preferred Practice Pattern® - PubMed
- Pivotal Trial Toward Effectiveness of Self-administered OCT in Neovascular Age-related Macular Degeneration. Report 2-Artificial Intelligence Analytics - PubMed
- The acceptability to patients with macular disease to have retreatment decisions being made by artificial intelligence | Eye Open
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
